Investor Alert

New York Markets Open in:

Gamida Cell Ltd.



After Hours

 --Quotes are delayed by 20 min

Nov 30, 2023, 7:59 p.m.





-0.01 -3.23%


Volume 24,201

Quotes are delayed by 20 min


Previous close

$ 0.32

$ 0.31


-0.0067 -2.12%

Day low

Day high




52 week low

52 week high




Julian Adams

Julian Adams is a businessperson who has been the head of 6 different companies. He holds the position of Chairman at Elicio Therapeutics, Inc. and Chairman of Elicio Therapeutics, Inc. (Old) (a subsidiary of Elicio Therapeutics, Inc.) and Chief Executive Officer & Director at Gamida Cell, Inc. Dr. Adams is also on the board of Gamida Cell Ltd. (former Chief Executive Officer & Director) and Princess Margaret Cancer Foundation.

In the past Dr. Adams was President & Chief Science Officer at Clal Biotechnology Industries Ltd. and President & Chief Science Officer at Clal Biotechnology Industries Ltd. (Venture Capital) (a subsidiary of Clal Biotechnology Industries Ltd.), President-Research & Development at Infinity Pharmaceuticals, Inc. and President at Infinity Discovery, Inc. (a subsidiary of Infinity Pharmaceuticals, Inc.), Medicinal Chemist at Merck & Co., Inc., Advisor at Limulus Management Co. LLC, Senior Vice President-Research & Development at LeukoSite, Inc., Director, Executive VP-Research & Development at ProScript, Inc., Senior Vice President-Drug Discovery & Development at Millennium Pharmaceuticals, Inc. and Director-Medicinal Chemistry at Boehringer Ingelheim Corp.

He received an undergraduate degree from McGill University and a doctorate from Massachusetts Institute of Technology.


Date Shares Transaction Value
10/19/2023 28,300   Award at $0 per share. 0
02/08/2023 28,300   Award at $0 per share. 0
11/18/2022 2,000   Award at $0 per share. 0
07/27/2022 68,800   Award at $0 per share. 0
07/27/2022 48,500   Award at $0 per share. 0

Officers and Executives

Ms. Abigail L. Jenkins
President, Chief Executive Officer & Director
Ms. Michele I. Korfin
Chief Operating & Commercial Officer
Ms. Mary Theresa Coelho
Chief Financial & Accounting Officer
Dr. Yona Geffen
Vice President-Research & Development
Dr. Ronit Simantov
Chief Medical & Scientific Officer
Mr. Vladimir Melnikov
Senior VP-Global Operations & Manufacturing
Mr. Joshua F. Patterson
Chief Compliance Officer & General Counsel
Mr. Yisrael Gewirtz
Internal Auditor
Ms. Heather DiVecchia
Director-Investor Relations & Communications
Ms. Shawn Cline Tomasello
Mr. Stephen T. Wills
Independent Director
Dr. Ivan M. Borrello
Independent Director
Dr. Julian Adams
Independent Director
Mr. Kenneth I. Moch
Independent Non-Executive Director
Link to MarketWatch's Slice.